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Background
Aged patients suffering from breast cancer are often
“undertreated” because of their presumed shorter life
expectancy, increasing comorbidity, and favorable tumor
biology.
The Consensus Conference Panel of Philadelphia
recommends SNB in patients with breast tumours
≤3 cm, although some authors have reported that this
technique is reliable also in elderly patients with larger
tumors.
T h ea i mo ft h i ss t u d yw a st oa s s e s st h es a f e t yo ft h e
procedure as well as the rate of axillary recurrences
after SNB in a series of old population.
Materials and methods
Between June 2007 and March 2009, we observed
122 female patients over 70 years old (range 70-85 years;
mean age 75.6 years) with breast cancer.
A comprehensive geriatric assessment (CGA) was
administered before and after surgery to assess the func-
tional status as well as comorbidity and quality of life.
Results
After CGA and anaesthesiologic examination, a total of
108 (88.5%) of 122 patients were candidates for surgery,
but 14 patients refused it. So 96 patients (89%) were
operated on.
Breast-conserving surgery was performed in 60
(62.5%) of the 96 patients, while a radical mastectomy
was performed in 36 (37%) patients.
A total of 77 (80.2%) of 96 patients underwent SNB;
30 (31%) had positive SNB (N+) and underwent axillary
lymphadenectomy. In the remaining 47 patients (49%),
SNB was negative (N0) for metastasis. At present, no
axillary recurrence was observed in the group of sentinel
node negative patients.
Discussion
Surgery is still the treatment of choice for primary
breast cancer in the geriatric population, in the context
of a multidisciplinary approach which needs to be
adapted to the patient’s health status.
The principles concerning geriatric evaluation in
elderly cancer patients before treatment, (CGA) establish
the necessity of some form of assessment for all patients
aged 70 and older.
The recent trend to substitute SNB can also be called
into question, particularly in patients with a clinically
negative axilla. There are few reports on the clinical
recurrence rate in patients treated with SNB due to the
short follow-up. Our study data suggest that SNB, when
indicated, gives information about axillary staging, and
spares patients aged ≥70 years unnecessary axillary
lymph node dissection.
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